Bullboard Post History

by Joemare

Order by:

T.TH	RE:RE:Article from Bloomberg of note Totally agree with you. Mgmt failed to create any value with the P.II... January 17, 2023
T.TH	Meanwhile, AKRO is at 2.4B$ market cap So so so bitter than the super executives and the super board of TH dropped... January 13, 2023
T.TH	RE:RE:RE:RE:RE:RE:RE:Hey THERA executives...any value?? It boils to how knowledgeable were they in onco phase I onco trials... January 12, 2023
T.TH	RE:RE:RE:Hey THERA executives...any value?? Please put the link - I think they need all the help they can to figure... January 11, 2023
T.TH	Hey THERA executives...any value?? Pathology 2023 Feb;55(1):40-51. doi: 10.1016/j.pathol.2022.08.001. Epub 2022... January 11, 2023
T.TH	RE:RE:National Bank On Th Oh my, so much has happened since December. Huge disappointment. Huge... January 5, 2023
T.TH	RE:Meanwhile, AKRO is a 2.5B$ company. 2.3B$. December 16, 2022
T.TH	Meanwhile, AKRO is a 2.5B$ company. Not sure they know where they are heading, other than celebrating new hirees.... December 16, 2022
T.TH	Anyone here know the strategy of TH1902 going forward? Isn't insane that it has not been communicated? What is the protocol... December 8, 2022
T.TH	Some investors are fed up with their incompentency We should start seeing large volumes being dumped. Disaster, indeed. December 6, 2022
T.TH	45-60 days prior to strategy update I believe it's the minimum time before FDA comes back with a final... December 5, 2022
T.TH	They knew for a longer time than we think Is sortilin the approach? Or is docetaxel the problem? I think... December 2, 2022
T.TH	RE:Heads need to role And clarity on NASH is required asap as well. No more wishy washy comments... December 2, 2022
T.TH	Heads need to role ASAP. Always a bad sign when biotech is mute on clinical trial updates... December 2, 2022
T.TH	Year-end finally. New corporate scorecard effective tomorrow Three week window for significant information before Christmas break. ... November 30, 2022
T.TH	RE:RE:RE:RE:Should NASH be revived FYI --- Just out. November 2022 publication: Causes... November 18, 2022
T.TH	RE:RE:RE:Should NASH be revived Although not permitted to support off-label use, curious to know if they know... November 18, 2022
T.TH	Should NASH be revived Through a partnerhsip or go at-it alone strategy, the valuation of THERF... November 18, 2022
T.TH	RE:Liking What We See, Initiating With OW & $9 PT - Summary Upcoming Catalysts and Events Exhibit 9: Catalysts and Events Calendar... November 17, 2022
T.TH	Liking What We See, Initiating With OW & $9 PT - Summary Investment Summary: We are initiating coverage of Theratechnologies... November 17, 2022

Become a member today, It's free!

Bullboard Post History

by Joemare

RE:RE:Article from Bloomberg of note

Meanwhile, AKRO is at 2.4B$ market cap

RE:RE:RE:RE:RE:RE:RE:Hey THERA executives...any value??

RE:RE:RE:Hey THERA executives...any value??

Hey THERA executives...any value??

RE:RE:National Bank On Th

RE:Meanwhile, AKRO is a 2.5B$ company.

Meanwhile, AKRO is a 2.5B$ company.

Anyone here know the strategy of TH1902 going forward?

Some investors are fed up with their incompentency

45-60 days prior to strategy update

They knew for a longer time than we think

RE:Heads need to role

Heads need to role

Year-end finally. New corporate scorecard effective tomorrow

RE:RE:RE:RE:Should NASH be revived

RE:RE:RE:Should NASH be revived

Should NASH be revived

RE:Liking What We See, Initiating With OW & $9 PT - Summary

Liking What We See, Initiating With OW & $9 PT - Summary

Featured News Links

Drilling Approval Received for New Mexico Lithium Project

This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition

IAMGOLD Reports First Quarter 2024 Results

Featured Company

Indiva Ltd V.NDVA

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Joemare

Featured News Links

Featured Company